{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05402384",
            "orgStudyIdInfo": {
                "id": "19-005271"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "AVTX-801 D-galactose Supplementation in SLC35A2-CDG",
            "officialTitle": "Evaluation of Efficacy and Safety of D-galactose Supplementation in SLC35A2-CDG, a Disorder of Hypogalactosylation",
            "therapeuticArea": [
                "Other"
            ],
            "study": "avtx-d-galactose-supplementation-in-cdg"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-28",
            "studyFirstSubmitQcDate": "2022-05-28",
            "studyFirstPostDateStruct": {
                "date": "2022-06-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-25",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Eva Morava-Kozicz",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Eva Morava-Kozicz",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multicenter, open-label, withdrawal and treatment study assessing the efficacy, safety, and tolerability of CERC-801 in subjects with SLC35A2-CDG."
        },
        "conditionsModule": {
            "conditions": [
                "SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Main study arm - AVTX-801",
                    "type": "EXPERIMENTAL",
                    "description": "subjects will wash out from food grade D-galactose then be put on medical grade D-galactose",
                    "interventionNames": [
                        "Drug: AVTX-801"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "placebo crossover",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "AVTX-801",
                    "description": "Medical grade D-galactose",
                    "armGroupLabels": [
                        "Main study arm - AVTX-801"
                    ],
                    "otherNames": [
                        "D-Galactose"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in the composite score of the Nijmegen Pediatric CDG Rating Scale",
                    "description": "Changes in the composite Nijmegen Pediatric CDG Rating Scale (NPCRS) score from post washout baseline to 12 months",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Change in Alanine aminotransferase level",
                    "description": "\u2022 Change in the key clinical laboratory parameters alanine aminotransferase \\[ALT\\], aspartate aminotransferase \\[AST\\]) from post-washout baseline to 12 months",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Change in Aspartate aminotransferase level",
                    "description": "\u2022 Change in the key clinical laboratory parameters alanine aminotransferase \\[ALT\\], aspartate aminotransferase \\[AST\\]) from post-washout baseline to 12 months",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria\n\n* Molecular diagnosis of SLC35A2-CDG\n* A parent or legal guardian must be available and willing to provide consent on behalf of minor subjects or adult subjects who are unable to give informed consent due to developmental disabilities.\n\nExclusion Criteria\n\n* Aldolase-B deficiency\n* Galactosemia\n* Hemolytic uremic syndrome\n* Hemoglobin \\< 7 mg/dL\n* Previously experienced severe AEs from oral galactose (severe diarrhea, vomiting, constipation, galactosuria, or increased liver glycogen storage)\n* Other history of galactose intolerance as determined by the investigator\n* Currently treated with ketogenic diet\n* Current enrollment in another trial involving investigational compounds\n* Dietary D-galactose supplementation\n* Use of investigational compounds\n* Pregnancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Genomics Research Team",
                    "role": "CONTACT",
                    "phone": "507-293-1139",
                    "email": "CGResearch@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Eva Morava-Kozicz, MD, PhD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Minnesota",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000018981",
                    "term": "Congenital Disorders of Glycosylation"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002239",
                    "term": "Carbohydrate Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21013",
                    "name": "Congenital Disorders of Glycosylation",
                    "asFound": "Congenital Disorders of Glycosylation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5498",
                    "name": "Carbohydrate Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1486",
                    "name": "Congenital Disorders of Glycosylation",
                    "asFound": "Congenital Disorders of Glycosylation",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5265",
                    "name": "SLC35A2-CDG",
                    "asFound": "SLC35A2-CDG",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}